Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Urinary Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02355886
What this trial is testing

Gabapentin in Reducing the Need for Pain Medication in Patients With Bladder Cancer Undergoing Radical Cystectomy

Who this might be right for
Bladder Carcinoma
University of Washington 25
Testing effectiveness (Phase 2)Study completedNCT00948961
What this trial is testing

CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

Who this might be right for
Advanced Malignancies
Celldex Therapeutics 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06310369
What this trial is testing

Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer

Who this might be right for
Bladder Cancer
European Organisation for Research and Treatment of Cancer - EORTC 50
Not applicableLooking for participantsNCT07820566
What this trial is testing

Development of a Preclinical 3D Vascularized and Perfused Tumoroid Model in Oncology and Urology Developed From Patient Tumors (Kidney, Bladder, and Prostate Cancers)

Who this might be right for
Kidney CancersBladder CancerProstate Cancer
University Hospital, Strasbourg, France 100
Not applicableLooking for participantsNCT06896162
What this trial is testing

PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

Who this might be right for
Solid Tumor MalignanciesMetastatic CancerBreast Cancer+3 more
UNC Lineberger Comprehensive Cancer Center 500
Testing effectiveness (Phase 2)Study completedNCT03929666
What this trial is testing

A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

Who this might be right for
HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
Jazz Pharmaceuticals 74
Very early researchStudy completedNCT03204266
What this trial is testing

Oral Supplementation to Enhance Recovery Pilot Study

Who this might be right for
Malignant Neoplasms of Urinary Tract
M.D. Anderson Cancer Center 46
Testing effectiveness (Phase 2)Study completedNCT00003105
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
Memorial Sloan Kettering Cancer Center 30
Not applicableStudy completedNCT05675176
What this trial is testing

Antegrade Observational Comparative Study for the Intravesical Instillation Therapy of Bacillus Calmette Guerin With the Use of Different Types of Urinary Catheters in Patients With Urinary Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder Cancer
National and Kapodistrian University of Athens 100
Early research (Phase 1)Active Not RecruitingNCT07118176
What this trial is testing

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Who this might be right for
Anal CarcinomaBladder CarcinomaBreast Carcinoma+31 more
Jonsson Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT02365766
What this trial is testing

Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects

Who this might be right for
Urothelial CarcinomaBladder Cancer
Jason R. Brown 83
Not applicableStudy completedNCT01304173
What this trial is testing

Retrospective Chart Review of Valstar

Who this might be right for
Carcinoma in Situ of Bladder
Endo USA Inc., a Keenova Therapeutics Company 113
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Not applicableStudy completedNCT02651246
What this trial is testing

Optional Sub-study to Intraoperative Imaging With ICG Registry

Who this might be right for
Lung, Prostate, Breast, Colon, Pancreatic, Renal, Bladder,Thyroid, Ovarian, Head and Neck,GI (Foregut - Esophagus),GI (Midgut) CancerCancer of the Ovarian, Head and Neck,GI (Foregut - Esophagus),GI (Midgut), Sarcoma CancerCancer of Neuro-onc, Parathyroid, Desmoid Tumors, Melanoma Cancer
Abramson Cancer Center at Penn Medicine 291
Testing effectiveness (Phase 2)Active Not RecruitingNCT04561362
What this trial is testing

Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

Who this might be right for
Urinary Bladder NeoplasmTriple Negative Breast NeoplasmsHormone Receptor Positive, HER2-negative Neoplasms+5 more
BicycleTx Limited 329
Not applicableStudy completedNCT01567462
What this trial is testing

PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder Tumors

Who this might be right for
Bladder Cancer
Emory University 95
Not applicableLooking for participantsNCT06011954
What this trial is testing

Survey Adults in South Korea With Cancer Who Receive PADCEV Injection

Who this might be right for
Urothelial Cancer
Astellas Pharma Korea, Inc. 202
Post-approval studies (Phase 4)Looking for participantsNCT06781879
What this trial is testing

Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder Cancer
Jakob Kristian Jakobsen 272
Testing effectiveness (Phase 2)Active Not RecruitingNCT04179162
What this trial is testing

Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG Treatment

Who this might be right for
Non-Muscle Invasive Bladder Cancer (NMIBC)
Memorial Sloan Kettering Cancer Center 54
Testing effectiveness (Phase 2)Ended earlyNCT02010203
What this trial is testing

HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT

Who this might be right for
Bladder Cancer
Heat Biologics 104
Next Page